Tariff Classification and the Country of Origin Marking Requirements for Three Human Blood Related Products, Hematopoietic Progenitor Cells, Bone Marrow Cells, and Therapeutic Cells
Reasoning
Tariff Classification and the Country of Origin Marking Requirements for Three Human Blood Related Products, Hematopoietic Progenitor Cells, Bone Marrow Cells, and Therapeutic Cells
Cite this ruling
CBP Ruling 968083 (3001900000): Tariff Classification and the Country of Origin Marking Requirements for Three Human Blood Related Products, Hematopoietic Progenitor Cells, Bone Marrow Cells, and Therapeutic Cells
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300190
The tariff classification of various tissue matrix, from the United States
The tariff classification of Grafton® Demineralized Bone Matrix (DBM) Allograft Products and Plexur™ P Biocomposite Human Allograft Tissue Products
The tariff classification of Silymarin and Chondroitin Sulfate, imported in bulk form, from China
The tariff classification of Bone Marrow and Hematopoietic Progenitor Cells (Apheresis Peripheral Blood Stem Cells- "PBSC") from various countries
The tariff classification of Heparin Sodium (CAS-9041-08-1) and Zoledronic Acid (CAS-165800-06-6), imported in bulk form, from Italy and India